Hepatitis A: Infection, detection, vaccination and immunity

Netherlands Journal of Medicine

Volumn 55, Issue 3, 1999, Pages 142-150

  Van Hattum, J ^a   Chen, X Q ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anti HAV; Hepatitis A vaccine; Hepatitis A virus; Immunology

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

CLINICAL FEATURE; DISEASE TRANSMISSION; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMORAL IMMUNITY; HYGIENE; JAUNDICE; PREVALENCE; REVIEW; VACCINATION; VIRUS REPLICATION;

ANTIBODIES, VIRAL; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

EID: 0032774483     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(99)00073-X     Document Type: Review

References (94)

1. Hadler SC. Global impact of hepatitis A virus infection changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, editors, Viral hepatitis and liver disease, Baltimore: Williams & Wilkins, 1991, pp. 14-20.
2. Krugman S, Giles JP, Hammond J. Infectious hepatitis: evidence for two distinctive clinical epidemiological and immunological types of infection. J Am Med Assoc 1967;200:365-73.
3. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973;182:1026-8.
4. Melnick JL. Classification of hepatitis A virus as enterovirus type 72 and of hepatitis B virus as hepadnavirus type 1. Intervirology 1982;18:105-6.
5. Minor P. Picornaviridae. In: Francki RIB, Fauquet CM, Knudson DL, Brown F, editors, Classification and nomenclature of viruses, Wien: Springer-Verlag, 1991, pp. 320-6, (Arch. Virol. Suppl. 2).
6. Siegl G. Virology of hepatitis A. In: Zuckerman AJ, editor, Viral hepatitis and liver disease, New York: Alan R Liss, 1988, pp. 3-7.
7. Brack K, Frings W, Dotzauer A, Vallbracht A. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol 1998;72:3370-6.
8. Coulepis AG, Locarnini SA, Lehmann NI, Gust ID. Detection of hepatitis A virus in the feces of patients with naturally acquired infections. J Infect Dis 1980;141:151-6.
9. Yotsuyanagi H, Koike K, Yasuda K et al. Prolonged fecal excretion of hepatitis A virus in adult patients with hepatitis A as determined by polymerase chain reaction. Hepatology 1996;24:10-3.
10. Zajac AJ, Amphllet EM, Rowlands DJ. Sangar DV. Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines. J Gen Virol 1991;72:1667-75.
11. Collier AJ, Wolstenholme AJ. The binding of hepatitis A virus to cell surfaces shows evidence of positive co-operativity. FEMS Microbiol Lett 1994;116:183-8.
12. Nainan OV, Brinton MA, Margolis HS. Identification of amino acids located in the antibody binding sites of human hepatitis A virus. Virology 1992;191:984-7.
13. Bosch A, González-Dankaart JF, Haro I, Gajardo R, Pérez JA, Pintó RM. A new continuous epitope of hepatitis A virus. J Med Virol 1998;54:95-102.
14. Shimizu YK, Mathiesen LR, Lorenz D et al. Localization of hepatitis A antigen in liver tissue by peroxidase-conjugated antibody method:light and electron microscopic studies. J Immunol 1978;121:1671-9.
15. Sheretz RJ, Russell BA, Reuman PD. Transmission of hepatitis A by transfusion of blood products. Arch Intern Med 1984;144:1579-84.
16. Steffen R, Kane MA, Shapiro CN, Billo N, Schoellhorn KJ, van Damme P. Epidemiology and prevention of hepatitis A in travelers. J Am Med Assoc 1994;272:885-9.
17. Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis 1997;25:726-8.
18. Severo CA, Abensur P, Buisson Y, Lafuma A, Detournay B, Pechevis M. An outbreak of hepatitis A in a French day-care center and efforts to combat it. Eur J Epidemiol 1997;13:139-44.
19. Goswami BB, Koch WH, Cebula TA. Detection of hepatitis A virus in Mercenaria mercenaria by coupled reverse transcription and polymerase chain reaction. Appl Environ Microbiol 1993;59:2765-70.
20. Vranckx R, Muylle L. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age. Infection 1990;18:364-6.
21. Higgins G, Wreghitt TG, Gray JJ, Blagdon J, Taylor CED. Hepatitis A virus antibody in East Anglian blood donors. Lancet 1990;336:1330.
22. Termorshuizen F, Van de Laar MJW. De epidemiologie van hepatitis A in Nederland, 1957-1998. Ned Tijdschr Geneeskd 1998;142:2364-8.
23. Yao GB. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In: Hollinger FB, Lemon SM, Margolis HS, editors, Viral hepatitis and liver disease, Baltimore: Williams & Wilkins, 1991, pp. 76-8.
24. Dalton CB, Haddix A, Hoffman RE, Mast EE. The cost of a food-borne outbreak of hepatitis A in Denver. Colo Arch Intern Med 1996;156:1013-6.
25. Van Hattum J, de Gast GC. Virale hepatitis, hepatitis A. In: van Furth R, de Geus AA, Hoepelman IM, van der Meer JWM, Verhoef J, editors, Nederlands leerboek der infectieziekten, Bohn: Scheltema Holkema, 1992, pp. 269-73.
26. Willner IR, Uhl MD, Howard SC, Williams EQ, Riely CA, Waters B. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med 1998;128:111-4.
27. Yotsuyanagi H, Iino S, Koike H, Yasuda K, Hino K, Kurokawa K. Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol 1993;40:35-8.
28. De la Rubia L, Del Pozo F, Carrasco M, De Rueda O, Cebrero M, De Frias E. Persistence of anti-HAV IgM antibodies and relapse of hepatitis type A in childhood. J Hepatol 1993;17:421-2.
29. Koff RS. Prolonged jaundice in hepatitis A. Gastrointest Dis Today 1994;3:10-6.
30. Zikos D, Grewal KS, Craig K, Cheng JC, Peterson DR, Fisher KA. Nephrotic syndrome and acute renal failure associated with hepatitis A virus infection. Am J Gastroenterol 1995;90:295-8.
31. Huppertz HI, Treichel U, Gassel AM, Jeschke R, Meyer zum Büschenfelde KH. Autoimmune hepatitis following hepatitis A virus infection. J Hepatol 1995;23:204-8.
32. Vento S, Garofano T, Renzini C et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. New Eng J Med 1998;338:286-90.
33. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with a chronic liver disease. Ann Intern Med 1989;110:838-9.
34. Eble K, Clemens J, Krenc C et al. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays. J Med Virol 1991;33:139-50.
35. Sata M, Nakano H, Tanaka E, Kumashiro R, Suzuki H, Tanikawa K. Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection. J Gastroenterol 1996;31:812-7.
36. Ochnio JJ, Scheifele DW, Ho M, Mitchell LA. New, ultrasensitive enzyme immunoassay for detecting vaccine-and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J Clin Microbiol 1997;35:98-101.
37. Locarnini SA, Garland SM, Lehmann NI, Pringle RC, Guist ID. Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A virus. J Clin Microbiol 1978;8:277-82.
38. Borovec S, Uren E. Single-antibody in situ enzyme immunoassay for infectivity titration of hepatitis A virus. 1997;68:81-7.
39. Jothikumar N, Cliver DO, Mariam TW. Immunomagnetic capture PCR for rapid concentration and detection of hepatitis A virus from environmental samples. Appl Environ Microbiol 1998;64:504-8.
40. Taylor M, Goldin RD, Ladva S, Scheuer PJ, Thomas HC. In situ hybridization studies of hepatitis A viral RNA in patients with acute hepatitis A. J Hepatol 1994;20:380-7.
41. Oren R, Shouval D, Tur-Kaspa R. Detection of hepatitis A virus RNA in serum from patients with acute hepatitis. J Med Virol 1989;28:261-3.
42. Fujiwara K, Yokosuka O, Ehata T et al. Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A. Hepatology 1997;26:1634-9.
43. Stapleton JT. Passive immunization against hepatitis A. Vaccine 1992;10(Suppl 1):S45-7.
44. Stapleton JT, Lange DK, LeDuc JW, Binn LN, Jansen RW, Lemon SM. The role of secretory immunity in hepatitis A virus infection. 1991;163:7-11.
45. Winokur PL, Stapleton JT. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis 1992;14:580-6.
46. Wang CH, Tschen SY, Heinrich U, Martin, Weber M, Flehmig B. Immune response to hepatitis A virus capsid proteins after infection. 1996;34:707-13.
47. Robertson BH, Jia XY, Tian H, Margolis HS, Summers DF, Ehrenfeld E. Antibody response to nonstructural proteins of hepatitis A virus following infection. J Med Virol 1993;40:76-82.
48. Zachoval R, Gauss-Müller V, Abb J, Zachoval V, Deinhardt F. Lymphocyte stimulation by hepatitis A virus in vitro. In: Zuckerman AJ, editor, Viral hepatitis and liver disease, New York: Alan R. Liss, 1988, pp. 65-6.
49. Vallbracht A, Maier K, Stierhof YD, Wiedmann KH, Flehmig B, Fleischer B. Liver-derived cytotoxic T cells in hepatitis A virus infection. J Infect Dis 1989;160:209-17.
50. Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. J Clin Lab Immunol 1993;40:47-60.
51. Vallbracht A, Stierhof YD, Fleischer B. Immunopathogenesis of hepatitis A virus infection. In: Meyer zum Büschenfeide KH, Hoofnagle JH, Manns M, editors, Immunology and liver, Dordrecht: Kluwer Academic, 1993, pp. 85-9.
52. Kägi D, Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic vs. noncytopathic viruses. Curr Opin Immunol 1996;8:472-7.
53. Kurane I, Binn LN, Bancroft WH, Ennis FA. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J Immunol 1985;135:2140-4.
54. Nachbaur K, Konig P, Rumpelt HJ, Schobel B, Lhotta K, Vogel W. Acute renal failure complicating non-fulminant hepatitis A. Clin Nephrol 1996;45:398-400.
55. Tsai JF, Margolis H, Jeng JE et al. Increased IgM class circulating immune complexes in acute hepatitis A virus infection. Clin Immunol Immunopathol 1996;78:291-5.
56. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Weekly Rep 1996;45:1-30.
57. Behrens RH, Doherty JF. Severe hepatitis A despite passive immunization. Lancet 1993;341:972.
58. Robertson BH, D'Hondt EH, Speibring J, Tian H, Krawczynski K, Margolis HS. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection. J Med Virol 1994;43:249-51.
59. CDC. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. Morb Mortal Weekly Rep 1994;43:506-9.
60. Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
61. Kodihalli S, Goto H, Kobasa DL, Krauss S, Kawaoka Y, Webster RG. DNA vaccine encoding hemaglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol 1999;73:2094-8.
62. Inchauspe G, Major ME, Nakano I, Vitvitski L, Trepo C. DNA vaccination for the induction of immune response against hepatitis C virus proteins. Vaccine 1997;15:853-6.
63. Provost PJ, Bishop RP, Gerety RJ et al. New finding in live, attenuated hepatitis A vaccine development. J Med Virol 1986;20:165-75.
64. Mao JS, Dong DX, Zhang HY et al. Primary study of attenuated live hepatitis A vaccine (H2 Strain) in humans. J Infect Dis 1989;159:621-4.
65. Mao JS, Chai SA, Xie RY et al. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine 1997;15:944-7.
66. Block SL, Hedrick JA, Tyler RD et al. Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA7) in rural Kentucky children. Pediatr Infect Dis 1993;12:976-80.
67. Victor J, Knudsen JD, Nielsen LP et al. Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted. Vaccine 1994;12:1327-9.
68. Garin D, Vidor E, Wallon M. Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults. Vaccine 1995;13:220-4.
69. Zanetti A, Pregliasco F, Andreassi A et al. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine? J Hepatol 1997;26:25-30.
70. Trorisi CL, Hollinger FB, Krause DS, Pickering LK. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®;SKB): a comparative study of two dosing schedules. Vaccine 1997;15:1613-7.
71. van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994;44:446-51.
72. van Doorslaer E, Tormans G, van Damme P. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. J Med Virol 1994;44:463-9.
73. Fenn P, McGuire A, Gray A. An economic evaluation of vaccination against hepatitis A for frequent travellers. J Inf 1998;36:17-22.
74. Neilsen GA, Bodsworth NJ, Watts N. Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men. J Infect Dis 1997;176:1064-7.
75. Buma APCCH, van Doornum GJJ, Veltink RL, van Ameijden EJC, Leentvaar-Kuijpers A, Coutinho RA. Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops. Vaccine 1997;15:1413-7.
76. Lee SD, Chan CY, Yu MI et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 1997;52:215-8.
77. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201-5.
78. Koff RS. Hepatitis A. The Lancet 1998;351:1643-9.
79. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. New Engl J Med 1997;336:196-204.
80. Duff B, Duff P. Hepatitis A vaccine: Ready for prime time. Obstetr Gynecol 1998;91:468-71.
81. Fan PC, Chang MH, Lee PI, Safary A, Lee CY. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: results after 5 years. Vaccine 1998;16:232-5.
82. Werzberger A, Mensch B, Kuter B et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. New Engl J Med 1992;327:453-7.
83. Innis BL, Snitbhan R, Kunasol P et al. Protection against hepatitis A by an inactivated vaccine. J Am Med Assoc 1994;271:1328-44.
84. Chen XQ, Bülbül M, de Gast GC, van Loon AM, Nalin DR, van Hattum J. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. J Hepatol 1997;26:260-4.
85. Zaaijer HL, Leentvaar-Kuijpers A, Rotman H, Lelie PN. Hepatitis A antibody titres after infection and immunization: Implications for passive and active immunization. J Med Virol 1993;40:22-7.
86. Miller WJ, Clark W, Hurni B, Kuter B, Schofield T, Nalin D. Sensitive assays for hepatitis A antibodies. J Med Virol 1993;41:201-4.
87. Lemon SM, Murphy PC, Provost PJ et al. Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin. J Infect Dis 1997;176:9-19.
88. Delem AD. Comparison of modified HAVAB and Elisa for determination of vaccine-induced anti-HAV response. Biologicals 1992;20:289-91.
89. Zuckerman JN, Powell L, Lequin RM, Zuckerman AJ. Determination of hepatitis A antibody response to vaccination by an enzyme immunoassay. J Virol Methods 1996;56:27-31.
90. Robbins DJ, Krater J, Kiang W et al. Detection of total antibody against hepatitis A virus by an automated microparticle enzyme immunoassay. J Virol Methods 1991;32:255-63.
91. Berger R, Just M, Althaus B. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used. J Virol Methods 1993;43:287-97.
92. Wiedermann G, Kundi M, Ambrosch F. Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule). Acta Trop 1998;69:121-5.
93. Chen XQ, de Gast GC, Wang RX, Boland GJ, Nalin DR, van Hattum J. T cell response after hepatitis A vaccination. Gastroenterology 1997;112:1241.
94. Chen XQ, de Gast GC, Wang RX, Boland GJ, Nalin DR, van Hattum J. B cell memory after hepatitis A vaccination, using 2 or 3 doses. Hepatology 1997;26:432.